Products billed under this code include ALBUMINEX 5%, Albumin (Human), Alburx, Albutein, Buminate, Plasbumin-5.
Payment limit per 50 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| ALBUMINEX 5% | Bio Products Laboratory USA, Inc. | 64208-2510-01 | 5 | $53.08 |
| ALBUMINEX 5% | Bio Products Laboratory USA, Inc. | 64208-2510-05 | 10 | $106.16 |
| Albumin (Human) | Octapharma USA | 68982-0623-01 | 2 | $21.232 |
| Albumin (Human) | Octapharma USA | 68982-0623-02 | 5 | $53.08 |
| Albumin (Human) | Octapharma USA | 68982-0623-03 | 10 | $106.16 |
| Alburx | CSL Behring | 44206-0310-25 | 5 | $53.08 |
| Alburx | CSL Behring | 44206-0310-50 | 10 | $106.16 |
| Albutein | Grifols | 68516-5214-00 | 20 | $212.32 |
| Albutein | Grifols | 68516-5214-01 | 5 | $53.08 |
| Albutein | Grifols | 68516-5214-02 | 10 | $106.16 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Albutein | Grifols | 68516-5214-05 | 1 | $10.616 |
| Albutein | Grifols | 68516-5214-09 | 20 | $212.32 |
| Albutein | Grifols | 68516-5218-04 | 20 | $212.32 |
| Albutein | Grifols | 68516-5219-02 | 20 | $212.32 |
| Buminate | Baxter | 00944-0491-01 | 5 | $53.08 |
| Buminate | Baxter | 00944-0491-02 | 10 | $106.16 |
| Plasbumin-5 | Talecris | 13533-0685-20 | 1 | $10.616 |
| Plasbumin-5 | Talecris | 13533-0685-25 | 5 | $53.08 |
| Plasbumin-5 | Talecris | 13533-0690-20 | 1 | $10.616 |
| Plasbumin-5 | Talecris | 13533-0690-25 | 5 | $53.08 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $10.616 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted September 17, 2026 |
| 3Q26 | $10.616 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted September 15, 2026 |
| 2Q26 | $10.616 | +$0.001 | 50 ML | Albumin (human),5%, 50ml | v1, posted September 15, 2026 |
| 1Q26 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted September 15, 2026 |
| 4Q25 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted September 8, 2026 |
| 3Q25 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted March 10, 2026 |
| 2Q25 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted March 10, 2026 |
| 1Q25 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted December 19, 2025 |
| 4Q24 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted June 11, 2025 |
| 3Q24 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted June 11, 2025 |
| 2Q24 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted March 11, 2025 |
| 1Q24 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted December 19, 2024 |
| 4Q23 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted October 10, 2024 |
| 3Q23 | $10.615 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted June 5, 2024 |
| 2Q23 | $10.615 | +$0.06 | 50 ML | Albumin (human),5%, 50ml | v1, posted February 23, 2024 |
| 1Q23 | $10.555 | +$0.065 | 50 ML | Albumin (human),5%, 50ml | v1, posted December 6, 2023 |
| 4Q22 | $10.49 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted June 22, 2023 |
| 3Q22 | $10.49 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted June 9, 2023 |
| 2Q22 | $10.49 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted December 14, 2022 |
| 1Q22 | $10.49 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted June 8, 2022 |
| 4Q21 | $10.49 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted June 2, 2022 |
| 3Q21 | $10.49 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted June 2, 2022 |
| 2Q21 | $10.49 | $0.00 | 50 ML | Albumin (human),5%, 50ml | v1, posted March 1, 2022 |
| 1Q21 | $10.49 | – | 50 ML | Albumin (human),5%, 50ml | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
